Surface plasmon resonance--more than a screening technology: insights in the binding mode of σ70:core RNAP inhibitors

Future Med Chem. 2014 Sep;6(14):1551-65. doi: 10.4155/fmc.14.105.

Abstract

Aim: Antibiotic resistance has become a major health problem. The σ(70):core interface of bacterial RNA polymerase is a promising drug target. Recently, the coiled-coil and lid-rudder-system of the β' subunit has been identified as an inhibition hot spot. Materials & methods & Results: By using surface plasmon resonance-based assays, inhibitors of the protein-protein interaction were identified and competition with σ(70) was shown. Effective inhibition was verified in an in vitro transcription and a σ(70):core assembly assay. For one hit series, we found a correlation between activity and affinity. Mutant interaction studies suggest the inhibitors' binding site.

Conclusion: Surface plasmon resonance is a valuable technology in drug design, that has been used in this study to identify and evaluate σ(70):core RNA polymerase inhibitors.

MeSH terms

  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology
  • Binding Sites
  • DNA-Directed RNA Polymerases / antagonists & inhibitors*
  • DNA-Directed RNA Polymerases / chemistry
  • DNA-Directed RNA Polymerases / metabolism
  • Enzyme Inhibitors / chemistry*
  • Enzyme Inhibitors / pharmacology
  • Escherichia coli / chemistry
  • Escherichia coli / drug effects
  • Escherichia coli / enzymology*
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / microbiology
  • Humans
  • Protein Binding
  • Protein Interaction Maps / drug effects
  • Small Molecule Libraries / chemistry*
  • Small Molecule Libraries / pharmacology
  • Surface Plasmon Resonance
  • Transcription, Genetic / drug effects

Substances

  • Anti-Bacterial Agents
  • Enzyme Inhibitors
  • Small Molecule Libraries
  • DNA-Directed RNA Polymerases